GlassScriptPhysician profile
Henry Raphael Rivera
NPI 1518005107
$1,195.12
in general payments reported to CMS, 2019-2025
10 companies · $53.72 in 2025
The $53.72 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $368 · 2023: $165 · 2024: $494 · 2025: $53.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $519.66 | 2022-2024 | Tagrisso, Enhertu, Lynparza |
| Exelixis INC. | $124.99 | 2022 | |
| Seagen INC. | $115.00 | 2021 | |
| Genzyme Corporation | $113.89 | 2024 | |
| Amgen INC. | $105.20 | 2022 | |
| Pfizer INC. | $98.30 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.87 | 2022 | |
| Collegium Pharmaceutical, INC. | $28.35 | 2025 | Jornay Pm |
| Cipher Pharmaceuticals US LLC | $25.37 | 2025 | Natroba, Spinosad |
| Ironshore Pharmaceuticals INC. | $18.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.